First patient treated in OneChain Immunotherapeutics’ CAR-T trial for cortical T-cell acute lymphoblastic leukemia
OneChain Immunotherapeutics announces the treatment of the first patient in the CARxALL clinical trial evaluating its most advanced product, OC-1. The trial, conducted in Barcelona at Hospital Clínic and Hospital Sant Joan de Déu, is open to both pediatric and adult patients worldwide. OneChain Immunotherapeutics is a spin-off of the Josep Carreras Leukaemia Research Institute […]